To this day, the contribution of centrosomal anomalies to cancer development remains controversial, with some studies showing that higher numbers, via Plk4 overexpression, can initiate or aggravate tumorigenesis [35, 36], and others showing that it is not sufficient and may even slow down progression [37, 38]. This evidence concerns the gene PLK4 and cancer.